Atara Biotherapeutics appoints Eric Dobmeier to its board of directors.
Atara Biotherapeutics announced that Eric Dobmeier has joined its Board of Directors. Mr. Dobmeier is currently the COO of Seattle Genetics, a biotechnology company. Mr. Dobmeier joined Seattle Genetics in March 2002 and, most recently as CBO from May 2007 to June 2011. March 27, 2015